OSTX

$1.54+0.04 (+2.67%)

Market ClosedAs of Mar 20, 8:00 PM UTC

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

Recent News